Edition:
United States

Magellan Health Inc (MGLN.OQ)

MGLN.OQ on NASDAQ Stock Exchange Global Select Market

70.70USD
21 Apr 2017
Change (% chg)

-- (--)
Prev Close
$70.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,014
52-wk High
$82.00
52-wk Low
$49.65

MGLN.OQ

Chart for MGLN.OQ

About

Magellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $1,676.80
Shares Outstanding(Mil.): 23.72
Dividend: --
Yield (%): --

Financials

  MGLN.OQ Industry Sector
P/E (TTM): 21.54 23.40 29.95
EPS (TTM): 3.28 -- --
ROI: 5.65 0.02 13.21
ROE: 7.19 14.57 14.38

BRIEF-Magellan health CEO Barry Smith's FY 2016 total compensation was $7.45 mln

* CEO Barry Smith's FY 2016 total compensation was $7.45 million versus $6.2 million - sec filing Source text : http://bit.ly/2p5SB75 Further company coverage:

Apr 12 2017

BRIEF-Magellan Health reports Q4 earnings per share $1.50

* Magellan Health reports fourth quarter 2016 and full year financial results

Feb 24 2017

BRIEF-Magellan Health enters into credit agreement that provides for a $200 mln delayed draw term loan

* Magellan Health Inc - On January 10, 2017 co entered into a credit agreement that provides for a $200.0 million delayed draw term loan - SEC filing

Jan 10 2017

BRIEF-KNF allows for re-materialization of Magellan's shares

Nov 23 Polish Financial Supervision Authority (KNF):

Nov 23 2016

BRIEF-Magellan Health provides 2017 financial guidance

* Magellan Health Inc - expects cash flow from operations in range of $186 million to $220 million in 2017

Nov 22 2016

BRIEF-Magellan Health to acquire Veridicus Holdings

* Closing of transaction is expected before end of year and is not subject to Hart-Scott-Rodino Ac

Nov 21 2016

BRIEF-Magellan Q3 net profit down at 9.9 mln zlotys yoy

* Q3 revenue 40.0 million zlotys ($9.9 million) versus 40.6 million zlotys year ago

Nov 10 2016

BRIEF-G. Scott Mackenzie appointed to Magellan Health board of directors

* G. Scott Mackenzie appointed to Magellan Health board of directors

Nov 03 2016

More From Around the Web

Earnings vs. Estimates